Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)

CAPS Rating: 5 out of 5

The Company is engaged in the discovery and development of synthetic DNA and RNA-based compounds for the treatment of cancer, infectious diseases, autoimmune diseases, and asthma/allergies, and for use as vaccine adjuvants.

Recs

0
Player Avatar davezzzz (49.47) Submitted: 1/26/2007 7:51:21 PM : Outperform Start Price: $7.67 IDRA Score: -85.57

Hey - it's just a random pick from the top performers list. What do I know? (not much)

Featured Broker Partners


Advertisement